These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23267232)

  • 1. Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.
    Ferguson LM; Dreisbach AW; Csongrádi E; Juncos LA; Fulop T
    Am J Med Sci; 2013 Mar; 345(3):256-8. PubMed ID: 23267232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A; Girndt M; Selejan S; Mathes A; Böhm M; Rensing H
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of Argatroban for anticoagulation in cardiovascular surgery.
    Ohteki H; Furukawa K; Ohnishi H; Narita Y; Sakai M; Doi K
    Jpn J Thorac Cardiovasc Surg; 2000 Jan; 48(1):39-46. PubMed ID: 10714019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?
    Follis F; Filippone G; Montalbano G; Floriano M; Lobianco E; D'Ancona G; Follis M
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):592-6. PubMed ID: 20061338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for continuous renal replacement therapy.
    Tolwani AJ; Wille KM
    Semin Dial; 2009; 22(2):141-5. PubMed ID: 19426417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban use during pediatric interventional cardiac catheterization.
    Cetta F; Graham LC; Wrona LL; Arruda MJ; Walenga JM
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):147-9. PubMed ID: 14696176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
    Ohno H; Yokoi M
    Masui; 2002 Jan; 51(1):30-3. PubMed ID: 11840659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis of the role of Argatroban in renal replacement therapy].
    Cao FF; Zhang HT; Feng X; Jiao RN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Dec; 35(6):667-71. PubMed ID: 24382247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study.
    Rössig L; Genth-Zotz S; Rau M; Heyndrickx GR; Schneider T; Gulba DC; Desaga M; Buerke M; Harder S; Zeiher AM;
    Int J Cardiol; 2011 Apr; 148(2):214-9. PubMed ID: 20226548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antithrombin and argatroban on disseminated intravascular coagulation parameters in a patient with septic shock.
    Beyer J; Halbritter K; Weise M; Schellong S
    Thromb Res; 2009 Jul; 124(3):383-6. PubMed ID: 19062078
    [No Abstract]   [Full Text] [Related]  

  • 12. Argatroban for anticoagulation during cardiac surgery.
    Martin ME; Kloecker GH; Laber DA
    Eur J Haematol; 2007 Feb; 78(2):161-6. PubMed ID: 17328717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D; Taylor M
    Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced argatroban doses after coronary artery bypass graft surgery.
    Hoffman WD; Czyz Y; McCollum DA; Hursting MJ
    Ann Pharmacother; 2008 Mar; 42(3):309-16. PubMed ID: 18303137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation.
    Major TC; Brisbois EJ; Jones AM; Zanetti ME; Annich GM; Bartlett RH; Handa H
    Biomaterials; 2014 Aug; 35(26):7271-85. PubMed ID: 24927680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac surgery in a patient with heparin-induced thrombocytopenia--cautions with use of the direct thrombin inhibitor, argatroban.
    Kurup V; Transue S; Wu Y; Rinder HM; Barash P; Dewar M
    Conn Med; 2006 Apr; 70(4):245-50. PubMed ID: 16768071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
    Kesson AM; Bellemore MC; O'Mara TJ; Ellis DH; Sorrell TC
    Clin Infect Dis; 2009 May; 48(9):1257-61. PubMed ID: 19320594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?
    Agarwal B; Shaw S; Shankar Hari M; Burroughs AK; Davenport A
    J Hepatol; 2009 Sep; 51(3):504-9. PubMed ID: 19615775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of cardiopulmonary bypass during cardiac surgery for patients with heparin-induced thrombocytopenia].
    Kondo T; Hirota M; Hoshino J; Fukada Y; Isomura T
    Kyobu Geka; 2013 May; 66(5):366-9. PubMed ID: 23674032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.